CTOs on the Move


 
With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.cordis.com
  • 5452 Betsy Ross Drive
    Santa Clara, FL USA 95054
  • Phone: 408.273.3700

Executives

Name Title Contact Details

Similar Companies

Novasyte

Novasyte partners with med-tech companies, offering outsourced commercial service teams for clinical, sales, field technical and recall support. Our flexible model enables us to build, deploy and manage teams that expand and contract to meet our clients` customer-facing needs. Program success is tracked and measured with our real-time business intelligence analytics that provide our clients with critical insights into their most important resources - their people and their customers.

BioAssay Systems

BioAssay Systems is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Medical supplies and equipment

American Medical supplies and equipment is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

prince frederick dental center

prince frederick dental center is a Prince Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medovex

Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies. Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies.